Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric monoclonal antibody, Human IgG1 (AM122) (MALS verified)
Produktgrößen
25 ug
£401,00
S1N-VM226-25UG
200 ug
£1614,00
S1N-VM226-200UG
Über dieses Produkt
- SKU:
- S1N-VM226
- Buffer:
- PBS (pH 7.4)
- translate.label.attr.clone:
- AM122
- Klonalität:
- Monoclonal
- Konjugat:
- Biotin
- Weitere Details:
- Biotinylated Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AM122) (S1N-VM226) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 Protein. As verified in competitive ELISA-based and pseudovirus-based neutralization assay, this chimeric monoclonal can potently neutralize all SARS-CoV-2 Variants of Concern (VOCs), including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1) and Delta (B.1.617.2).
- Immunogen:
- Spike RBD
- Physischer Zustand:
- Powder
- Aufreinigung:
- 0.95
- Reaktivitäten:
- Mouse
- Versandbedingungen:
- Ambient
- Lagerbedingungen:
- -20[o]C
- Hersteller:
- ACRO Biosystems
- Typ:
- Antibody: Monoclonal Antibody
